Conference Coverage

VIDEO: How to prevent, manage perinatal HIV infection


 

AT IDSOG

– Despite notable progress in recent years, there’s room to further reduce perinatal HIV infection in the United States. Early recognition and treatment of HIV infection in pregnancy, prophylaxis for at-risk women, and retention of infected women in postpartum HIV care remain important goals, but they aren’t always met.

In a wide-ranging interview at the annual scientific meeting of the Infectious Diseases Society for Obstetrics and Gynecology, Gweneth Lazenby, MD, associate professor of obstetrics and gynecology at the Medical University of South Carolina, Charleston, explained what to do to improve the situation. Among the many pearls she shared: One HIV test isn’t enough for at-risk women.

Recommended Reading

Zika-related birth defects up in recent weeks
MDedge Infectious Disease
All isn’t well with HIV-exposed uninfected infants
MDedge Infectious Disease
ACIP approves new influenza vaccine recommendations
MDedge Infectious Disease
Asymptomatic maternal Zika infection doesn’t dampen birth defect risk
MDedge Infectious Disease
Preventing Zika in pregnancy: What you need to know
MDedge Infectious Disease
Antiviral shows early promise for treatment of Zika infection
MDedge Infectious Disease
Early neuroimaging essential for Zika-exposed neonates
MDedge Infectious Disease
CDC refocuses Zika testing recommendations in pregnancy
MDedge Infectious Disease
First trimester antibiotics may increase birth defect risk
MDedge Infectious Disease
Prenatal ART regimen with lowest risk is TDF-FTC-EFV
MDedge Infectious Disease